论文部分内容阅读
目的 :评价普米克、万托林和爱全乐雾化溶液联合应用佐治小儿毛细支气管炎 (毛支 )的疗效。方法 :将 76例毛支患儿随机分为两组 ,两组均采用综合治疗 ,治疗组加用三联药物压力雾化吸入治疗 ,对照组加用口服博利康尼和静脉点滴琥珀酸氢化可的松 ,评价治疗前后症状体征的变化。结果 :治疗组治愈率 84 2 %,对照组治愈率 92 1%,两组长疗效比较 ,P >0 0 5 ,差异无显著性意义。结论 :普米克、万托林和爱全乐三联雾化吸入佐治毛支疗效满意 ,且方便、毒副作用小 ,能逐渐取代全身用支气管扩张剂和皮质激素。
OBJECTIVE: To evaluate the curative effect of Pulmicort, Vantholin and AQQLE atomized solution in combination with pediatric bronchiolitis (bronchiolitis). Methods: A total of 76 children with bronchiolitis were randomly divided into two groups. The two groups were treated by combination therapy. The treatment group was treated with triple drug pressure atomization inhalation. The control group was treated with oral rivasolib and intravenous succinate hydrogenation Song, evaluation of symptoms and signs before and after treatment changes. Results: The cure rate was 84.2% in the treatment group and 92.1% in the control group. There was no significant difference between the two groups in long-term efficacy (P> 0.05). Conclusion: Pulmicort, Wan Tolrine and Astrakhan inhalation triple therapy hairpin with satisfactory results, and convenient, side effects, can gradually replace the systemic bronchodilators and corticosteroids.